company background image
TNXP logo

Tonix Pharmaceuticals Holding NasdaqCM:TNXP Stock Report

Last Price

US$0.19

Market Cap

US$19.2m

7D

-46.0%

1Y

-95.2%

Updated

28 Mar, 2024

Data

Company Financials +

Tonix Pharmaceuticals Holding Corp.

NasdaqCM:TNXP Stock Report

Market Cap: US$19.2m

TNXP Stock Overview

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering.

TNXP fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Tonix Pharmaceuticals Holding Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tonix Pharmaceuticals Holding
Historical stock prices
Current Share PriceUS$0.19
52 Week HighUS$4.00
52 Week LowUS$0.17
Beta2.29
1 Month Change-49.46%
3 Month Change-53.85%
1 Year Change-95.16%
3 Year Change-99.92%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Tonix stock rises on FDA nod to start trial of TNX-601 for depression

Oct 03

Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23

Aug 08

Tonix announces partnership to study monkeypox vaccine in 1H 2023

Jul 28

Tonix Pharma to develop extended-release form of depression therapy

Jul 11

Is Tonix Pharma's Stock A Buy Or Sell After Buyback Plan Announcement?

Jun 21

Tonix to develop candidate as potential treatment for Long COVID Syndrome

Jun 21

Shareholder Returns

TNXPUS BiotechsUS Market
7D-46.0%0.9%0.4%
1Y-95.2%10.3%28.8%

Return vs Industry: TNXP underperformed the US Biotechs industry which returned 10.3% over the past year.

Return vs Market: TNXP underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is TNXP's price volatile compared to industry and market?
TNXP volatility
TNXP Average Weekly Movement16.2%
Biotechs Industry Average Movement11.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: TNXP's share price has been volatile over the past 3 months.

Volatility Over Time: TNXP's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2007117Seth Ledermanhttps://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its development portfolio focuses on central nervous system disorders.

Tonix Pharmaceuticals Holding Corp. Fundamentals Summary

How do Tonix Pharmaceuticals Holding's earnings and revenue compare to its market cap?
TNXP fundamental statistics
Market capUS$19.16m
Earnings (TTM)-US$123.42m
Revenue (TTM)US$3.99m

2.7x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TNXP income statement (TTM)
RevenueUS$3.99m
Cost of RevenueUS$2.37m
Gross ProfitUS$1.62m
Other ExpensesUS$125.04m
Earnings-US$123.42m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.11
Gross Margin40.49%
Net Profit Margin-3,094.01%
Debt/Equity Ratio0%

How did TNXP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.